The relationship between circulating markers of vascular dysfunction and neuroinflammation.
Novo Nordisk CEO skeptical of PBM promises in Senate hearing on weight loss drug prices
Sen. Bernie Sanders (I-VT) told Novo Nordisk CEO Lars Fruergaard Jørgensen that three major pharmacy benefit managers have agreed not to penalize the company for